A Platform Study for solId orgaN CancERs
Recruiting now
Conditions studied: Cancer, Surgery
In brief
Generating bespoke biosampling protocols for individual tumour specific translational projects is onerous, cumbersome and inefficient. This study aims to provide a broad platform to maximise the unique access to biopsy and resected tumour specimens available from cancer patients to provide a high-quality and efficient source of biosamples for specific translational projects. Access to historical FFPE samples and clinical data, as well as prospective fresh tissue samples, will allow interrogation of the underlying biology of these cancers. Matched pseudoanonymised clinical and radiological data will allow the development of rich high-yield datasets.
Key facts
- Study ID
- NCT05650125
- Run by
- University of Liverpool
- People needed
- 2000
- Starts
- 2022-01-01
- Expected to finish
- 2030-01-01
- Last updated by the study team
- 2025-08-01
Who can join
Age: 16 and older, up to 100. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Biopsy or surgical resection as standard of care
You may not qualify if…
- Refusal or inability to consent, paediatric patients
Where it is running
- University of Liverpool — Liverpool, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.